Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy

A Vezzani, S Balosso, T Ravizza - Nature Reviews Neurology, 2019 - nature.com
Epilepsy is a chronic neurological disease characterized by an enduring propensity for
generation of seizures. The pathogenic processes of seizure generation and recurrence are …

Inflammation and reactive oxygen species as disease modifiers in epilepsy

G Terrone, S Balosso, A Pauletti, T Ravizza… - …, 2020 - Elsevier
Neuroinflammation and reactive oxygen and nitrogen species are rapidly induced in the
brain after acute cerebral injuries that are associated with an enhanced risk for epilepsy in …

Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies

EA van Vliet, E Aronica, A Vezzani… - Neuropathology and …, 2018 - Wiley Online Library
Accumulating evidence indicates an important pathophysiological role of brain inflammation
in epilepsy. In this review, we will provide an update of specific inflammatory pathways that …

Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management

C Rawat, S Kukal, UR Dahiya, R Kukreti - Journal of neuroinflammation, 2019 - Springer
Epilepsy, a common multifactorial neurological disease, affects about 69 million people
worldwide constituting nearly 1% of the world population. Despite decades of extensive …

Epilepsy and inflammation in the brain: overview and pathophysiology: epilepsy and inflammation in the brain

A Vezzani - Epilepsy currents, 2014 - journals.sagepub.com
The possibility that inflammatory processes in the brain contribute to the etiopathogenesis of
seizures and the establishment of a chronic epileptic focus is increasingly recognized as a …

Inflammation and prevention of epileptogenesis

T Ravizza, S Balosso, A Vezzani - Neuroscience letters, 2011 - Elsevier
CNS injuries such as trauma, stroke, viral infection, febrile seizures, status epilepticus
occurring either in infancy or during a lifetime are considered common risk factors for …

Pharmacological targeting of brain inflammation in epilepsy: Therapeutic perspectives from experimental and clinical studies

T Ravizza, A Vezzani - Epilepsia open, 2018 - Wiley Online Library
Increasing evidence supports a pathogenic role of unabated neuroinflammation in various
central nervous system (CNS) diseases, including epilepsy. Neuroinflammation is not a …

Therapeutic role of targeting mTOR signaling and neuroinflammation in epilepsy

SL Hodges, JN Lugo - Epilepsy research, 2020 - Elsevier
Existing therapies for epilepsy are primarily symptomatic and target mechanisms of neuronal
transmission in order to restore the excitatory/inhibitory imbalance in the brain after seizures …

Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus

GE Serrano, N Lelutiu, A Rojas, S Cochi… - Journal of …, 2011 - Soc Neuroscience
Cyclooxygenase-2 (COX-2), a source of inflammatory mediators and a multifunctional
neuronal modulator, is rapidly induced in select populations of cortical neurons after status …

The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy

N Polascheck, M Bankstahl, W Löscher - Experimental neurology, 2010 - Elsevier
The enzyme cyclooxygenase-2 (COX-2), which catalyzes the production of pro-inflammatory
prostaglandins, is induced in the brain after various insults, thus contributing to brain …